Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

NCT04711915 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Depression

Interventions

DRUG: 0.1 mg/kg Dimethyltryptamine (DMT)
DRUG: 0.3 mg/kg Dimethyltryptamine (DMT)

Sponsor

Yale University